Aged-Related Changes in the Nails

  • John Montgomery YostEmail author


  • A number of age-related changes to the nails can occur, without known association with medical disorders.

  • Some nail changes can be associated with underlying medical disorders, enriched in older adults.

  • Hence, recognition of specific nail changes and their potential associations can be clues to medical issues that should not be missed.

  • Brittle nail syndrome, onychomycosis, and nail-associated malignancies are increased in older adults, and treatment requires special considerations in this population.


Nail changes Nail disorders Tumors of the nail apparatus Brittle nails Onychomycosis 


  1. 1.
    Chang AL, Wong JW, Endo JO, Norman RA. Geriatric dermatology review: major changes in skin function in older patients and their contribution to common clinical challenges. J Am Med Dir Assoc. 2013;14(10):724–30.PubMedGoogle Scholar
  2. 2.
    Cohen PR, Scher RK. Geriatric nail disorders: diagnosis and treatment. J Am Acad Dermatol. 1992;26(4):521–31.PubMedGoogle Scholar
  3. 3.
    de Berker DAR, Richert B, Baran R. The nail in childhood and old age. In: Baran R, de Berker DAR, Holzbert M, Thomas L, editors. Baran & Dawber’s diseases of the nails and their management. 4th ed. Oxford: Blackwell; 2012. p. 183–209.Google Scholar
  4. 4.
    Cohen PR, Scher RK. Nails in older individuals. In: Scher RK, Daniel CR, editors. Nails: diagnosis, therapy, surgery. 3rd ed. Philadelphia: Saunders; 2005. p. 245–64.Google Scholar
  5. 5.
    Cohen PR. The lunula. J Am Acad Dermatol. 1996;34(6):943–53.PubMedGoogle Scholar
  6. 6.
    Terry R. White nails in hepatic cirrhosis. Lancet. 1954;266(6815):757–9.PubMedGoogle Scholar
  7. 7.
    Lindsay PG. The half-and-half nail. Arch Intern Med. 1967;119(6):583–7.PubMedGoogle Scholar
  8. 8.
    Muehrcke RC. The finger-nails in chronic hypoalbuminaemia: a new physical sign. Br Med J. 1956;1(4979):1327–8.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Stone OJ. Clubbing and koilonychia. Dermatol Clin. 1985;3(3):485–90.PubMedGoogle Scholar
  10. 10.
    Baran R, Haneke E, Richert B. Pincer nails: definition and surgical treatment. Dermatol Surg. 2001;27(3):261–6.PubMedGoogle Scholar
  11. 11.
    Baran R, Broutard JC. Epidermoid cyst of the thumb presenting as pincer nail. J Am Acad Dermatol. 1998;19:143–4.Google Scholar
  12. 12.
    Greiner D, Schöfer H, Milbradt R. Reversible transverse overcurvature of the nails (pincer nails) after treatment with a β-blocker. J Am Acad Dermatol. 1998;39:486–7.PubMedGoogle Scholar
  13. 13.
    Jemec GBE, Thomsen K. Pincer nails and alopecia as markers of gastrointestinal malignancy. J Dermatol. 1997;24:479–81.PubMedGoogle Scholar
  14. 14.
    Majeski C, Richie B, Giuffre M, Lauzon G. Pincer nail deformity associated with systemic lupus erythematosis. J Cutan Med Surg. 2005;9(1):2–5.PubMedGoogle Scholar
  15. 15.
    Okada K, Okada E. Novel treatment using thioglycolic acid for pincer nails. J Dermatol. 2012;39(12):996–9.PubMedGoogle Scholar
  16. 16.
    Tseng JT, Ho WT, Hsu CH, Lin MH, Li CN, Lee WR. A simple therapeutic approach to pincer nail deformity using a memory alloy: measurement of response. Dermatol Surg. 2013;39(3):398–405.PubMedGoogle Scholar
  17. 17.
    Kim JY, Park SY, Yoon HS, Cho S, Park HS. Quick and easy correction of a symptomatic pincer nail using a shape memory alloy device. Dermatol Surg. 2013;39(10):1520–6.PubMedGoogle Scholar
  18. 18.
    Nam HM, Kim UK, Park SD, Kim JH, Park K. Correction of pincer nail deformity using dermal grafting. Ann Dermatol. 2011;23 Suppl 3:S299–302.PubMedCentralPubMedGoogle Scholar
  19. 19.
    Lin CT, Chen TM. Regarding assisting pincer nail deformity by Haneke’s procedure. Dermatol Surg. 2013;39(8):1287–8.PubMedGoogle Scholar
  20. 20.
    Jemec GBE, Kollerup G, Jensen LB, Mogensen S. Nail abnormailities in nondermatologic patients: prevalence and possible role as diagnostic aids. J Am Acad Dermatol. 1995;32(6):977–81.PubMedGoogle Scholar
  21. 21.
    Baran R. The nail in the elderly. Clin Dermatol. 2011;9(1):54–60.Google Scholar
  22. 22.
    Baran R. Nail care in the “golden years” of life. Curr Med Res Opin. 1982;7 Suppl 2:95–7.PubMedGoogle Scholar
  23. 23.
    Lubach D, Cohrs W, Wurzinger R. Incidence of brittle nails. Dermatologica. 1986;172:144–7.PubMedGoogle Scholar
  24. 24.
    Stern DK, Diamantis S, Smith E, Wei H, Gordon M, Muigai W, et al. Water content and other aspects of brittle versus normal fingernails. J Am Acad Dermatol. 2007;57:31–6.PubMedGoogle Scholar
  25. 25.
    Duarte AF, Correia O, Baran R. Nail plate cohesion seems to be water independent. Int J Dermatol. 2009;48:193–5.PubMedGoogle Scholar
  26. 26.
    Forslind B. Biophysical studies on the normal nail. Acta Derm Venereol. 1970;50(3):161–8.PubMedGoogle Scholar
  27. 27.
    Farran L, Ennos AR, Eichhorn SJ. The effect of humidity on fracture properties of human fingernails. J Exp Biol. 2008;211:3677–81.PubMedGoogle Scholar
  28. 28.
    Sasaki M, Kusubata M, Akamatsu H. Biochemical analysis of keratin in the brittle nail. J Invest Dermatol. 2008;128(Suppl 1s):S91.Google Scholar
  29. 29.
    Lubach D, Beckers P. Wet working conditions increase brittleness of nails but do not cause it. Dermatology. 1992;185:120–213.PubMedGoogle Scholar
  30. 30.
    Dimitris R, Daniel CR. Management of simple brittle nails. Dermatol Ther. 2012;25(6):569–73.PubMedGoogle Scholar
  31. 31.
    Shemer A, Daniel CR. Common nail disorders. Clin Dermatol. 2013;31(5):578–86.PubMedGoogle Scholar
  32. 32.
    van de Kerkhof PCM, Pasch MC, Scher RK, Kerscher M, Gieler U, Haneke E, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005;53(4):644–51.PubMedGoogle Scholar
  33. 33.
    Zarzour JG, Singh S, Andea A, Cafardi JA. Acrokeratosis paraneoplastica (Bazex syndrome): report of a case associated with small cell lung cancer and a review of the literature. J Radiol Case Rep. 2011;5(7):1–6.PubMedCentralPubMedGoogle Scholar
  34. 34.
    Cashman MW, Sloan SB. Nutrition and nail disease. Clin Dermatol. 2010;28(4):420–5.PubMedGoogle Scholar
  35. 35.
    Salem A, Al Mokadem S, Attwa E, Abd El Raoof S, Ebrahim HM, Faheem KT. Nail changes in chronic renal failure patients under haemodialysis. J Eur Acad Dermatol Venereol. 2008;22(11):1326–31.PubMedGoogle Scholar
  36. 36.
    Chao SC, Lee JY. Brittle nails and dyspareunia as first clues to recurrences of malignant glucagonoma. Br J Dermatol. 2002;146(6):1071–4.PubMedGoogle Scholar
  37. 37.
    Geyer A, Scher RK, Uyttendaele H. Brittle nails: pathogenesis and treatment. J Drugs Dermatol. 2003;2(1):48–9.PubMedGoogle Scholar
  38. 38.
    Iorizzo M, Pazzaglia M, Piraccini BM, Tullo S, Tosti A. Brittle nails. J Cosmet Dermatol. 2004;3(3):138–44.PubMedGoogle Scholar
  39. 39.
    Sparavigna A, Setaro M, Genet M, Frisenda L. Equisetum arvense in a new transungual technology improves nail structure and appearance. J Plast Dermatol. 2006;2(1):31–8.Google Scholar
  40. 40.
    Goldstein B, Nasir A, Swick L, van Cleeff M. Clinical evaluation of safety and efficacy of a new topical treatment for onychomycosis. J Drugs Dermatol. 2011;10(10):1186–91.PubMedGoogle Scholar
  41. 41.
    Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. Cutis. 1993;51(4):303–5.PubMedGoogle Scholar
  42. 42.
    Sherber NS, Hoch AM, Coppola CA, Carter EL, Chang HL, Barsanti FR, et al. Efficacy and safety study of tazarotene cream 0.1 % for the treatment of brittle nail syndrome. Cutis. 2011;87(2):96–103.PubMedGoogle Scholar
  43. 43.
    Sobera JO, Elewski BE. Onychomycosis. In: Scher RK, Daniel CR, editors. Nails: diagnosis, therapy, surgery. 3rd ed. Philadelphia: Saunders; 2005. p. 123–40.Google Scholar
  44. 44.
    Ghannoum MD, Hajjeh RA, Scher R. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distributions, and antifungal susceptibility patterns. J Am Acad Dermatol. 2000;43:641–8.PubMedGoogle Scholar
  45. 45.
    Elewski B, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol. 1997;133:1172–3.PubMedGoogle Scholar
  46. 46.
    Thomas J, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H, Sharpe C. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther. 2010;35(5):497–519.PubMedGoogle Scholar
  47. 47.
    Hay RJ, Baran R. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol. 2011;65(6):1219–27.PubMedGoogle Scholar
  48. 48.
    Daniel CR, Norton LA, Scher RK. The spectrum of nail disease in patients with human immunodeficiency virus infection. J Am Acad Dermatol. 1992;27:93–7.PubMedGoogle Scholar
  49. 49.
    Baran R. Proximal subungual Candida onychomycosis: an unusual manifestation of chronic mucocutaneous candidiasis. Br J Dermatol. 1997;137:286–8.PubMedGoogle Scholar
  50. 50.
    Rich P, Elewski B, Scher RK, Pariser D. Diagnosis, clinical implications, complications of onychomycosis. Semin Cutan Med Surg. 2013;32(2 Suppl 1):S5–8.PubMedGoogle Scholar
  51. 51.
    Wilsmann-Theis D, Bieber T, Schmid-Wendtner MH, Wenzel J. New reasons for histopathological nail-clipping examination in the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol. 2011;25(2):235–7.PubMedGoogle Scholar
  52. 52.
    Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8 % in the treatment of toenail onychomycosis. J Am Acad Dermatol. 2000;43(4 Suppl):S70–80.PubMedGoogle Scholar
  53. 53.
    Baran R, Coquard F. Combination of fluconazole and urea in a nail laquer for treating onychomycosis. J Dermatolog Treat. 2005;16(1):52–5.PubMedGoogle Scholar
  54. 54.
    Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, et al. Efinaconazole 10 % solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol. 2013;68(4):600–8.PubMedGoogle Scholar
  55. 55.
    Del Rosso JQ, Reece B, Smith K, Miller T. Efinaconazole 10 % solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential. J Clin Aesthet Dermatol. 2013;6(3):20–4.Google Scholar
  56. 56.
    Baker SJ, Zhang YK, Akama T, Lau A, Zhou H, Hernandez V, et al. Discovery of a new boron containing anti-fungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-,1-benzoxaborole (AN2690), for the potential treatment of onychomycosis. J Med Chem. 2006;49(15):4447–50.PubMedGoogle Scholar
  57. 57.
    Elewski BE, Tosti A. Tavaborole for the treatment of onychomycosis. Expert Opin Pharmacother. 2014;15(10):1439–48.PubMedGoogle Scholar
  58. 58.
    Roberts DR, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol. 2003;148:402–10.PubMedGoogle Scholar
  59. 59.
    Loo DS. Onychomycosis in the elderly: drug treatment options. Drugs Aging. 2007;24(4):293–302.PubMedGoogle Scholar
  60. 60.
    Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. Treatment options—development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:25–33.PubMedGoogle Scholar
  61. 61.
    Roberts DT, Evans EG. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol. 1998;138(1):189–90.PubMedGoogle Scholar
  62. 62.
    Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamics and pharmokinetic properties, and therapeutic potential in superficial mycoses. Drugs. 1992;43(2):259–84.PubMedGoogle Scholar
  63. 63.
    Piraccini BM, Sisti A, Tosti A. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol. 2010;62(3):411–4.PubMedGoogle Scholar
  64. 64.
    Yin Z, Xu J, Luo D. A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole. J Dermatolog Treat. 2012;23(6):449–52.PubMedGoogle Scholar
  65. 65.
    de Sá DC, Lamas AP, Tosti A. Oral therapy for onychomycosis: an evidence-based review. Am J Clin Dermatol. 2014;15(1):17–36.PubMedGoogle Scholar
  66. 66.
    Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol. 2004;150:537–44.PubMedGoogle Scholar
  67. 67.
    Gupta AK, Paquet M, Simpson F, Tavakkol A. Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol. 2013;27(3):267–72.PubMedGoogle Scholar
  68. 68.
    Sigurgeirsson B, Billstein S, Rantanen T, Ruzicka T, di Fonzo E, Vermeer BJ, et al. L.I.O.N. Study: efficacy and tolerablility of continuous terbinafine (Lamisil®) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Br J Dermatol. 1999;141 Suppl 56:5–14.PubMedGoogle Scholar
  69. 69.
    Drake LA, Shear NH, Arlette JP, Cloutier R, Danby FW, Elewski BE, et al. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial. J Am Acad Dermatol. 1997;37(5 Pt 1):740–5.PubMedGoogle Scholar
  70. 70.
    Shapiro LE, Shear NH. Drug interactions: proteins, pumps, and P-450s. J Am Acad Dermatol. 2002;47(4):467–88.PubMedGoogle Scholar
  71. 71.
    Elewski BE. Mechanism of action of systemic antifungal agents. J Am Acad Dermatol. 1993;28(5 Pt 1):S28–34.PubMedGoogle Scholar
  72. 72.
    Ahmad SR, Singer SJ, Leissa BG. Congestive heart failure associated with itraconazole. Lancet. 2001;357(9270):1766–7.PubMedGoogle Scholar
  73. 73.
    Onmel (itraconazole) [package insert]. Greensboro, NC: Merz Pharmaceuticals, LLC; 2012.Google Scholar
  74. 74.
    Cathcart S, Cantrell W, Elewski BE. Onychomycosis and diabetes. J Eur Acad Dermatol Venereol. 2009;23(10):1119–22.PubMedGoogle Scholar
  75. 75.
    Gupta AK, Konnikov N, Lynde CW. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. J Am Acad Dermatol. 2001;44(3):479–84.PubMedGoogle Scholar
  76. 76.
    Tavakkol A, Fellman S, Kianifard F. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamasil and Debridement (IRON-CLAD), an open-label, randomized trial. Am J Geriatr Pharmacother. 2006;4(1):1–13.PubMedGoogle Scholar
  77. 77.
    Ortiz AE, Avram MM, Wanner MA. A review of lasers and light for the treatment of onychomycosis. Lasers Surg Med. 2014;46(2):117–24.PubMedGoogle Scholar
  78. 78.
    Hollmig ST, Rahman Z, Henderson MT, Rotatori RM, Gladstone H, Tang JY. Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: a randomized controlled trial. J Am Acad Dermatol. 2014;70(5):911–7.PubMedGoogle Scholar
  79. 79.
    Domínguez-Cherit J, Chanussot-Deprez C, Maria-Sarti H, Fonte-Avalos V, Vega-Memije E, Luis-Montoya P. Nail unit tumors: a study of 234 patients in the dermatology department of the “Dr Manuel Gea González” General Hospital in Mexico City. Dermatol Surg. 2008;34(10):1363–71.PubMedGoogle Scholar
  80. 80.
    Salsache SJ, Orengo IF. Tumors of the nail unit. J Dermatol Surg Oncol. 1992;18(8):691–700.Google Scholar
  81. 81.
    Tosti A, Richert B, Pazzaglia M. Tumors of the nail apparatus. In: Scher RK, Daniel CR, editors. Nails: diagnosis, therapy, surgery. 3rd ed. Philadelphia: Saunders; 2005. p. 195–204.Google Scholar
  82. 82.
    Lin YC, Wu YH, Scher RK. Nail changes and association of osteoarthritis in digital myxoid cyst. Dermatol Surg. 2008;34(3):364–9.PubMedGoogle Scholar
  83. 83.
    Drapé JL, Idy-Peretti I, Goettmann S, Salon A, Abimelec P, Guérin-Surville H, et al. MR imaging of digital mucoid cysts. Radiology. 1996;200(2):531–6.PubMedGoogle Scholar
  84. 84.
    De Berker DA, Lawrence CM. Treatment of myxoid cysts. Dermatol Surg. 2001;27(3):296–9.PubMedGoogle Scholar
  85. 85.
    Epstein E. A simple technique for managing digital mucous cysts. Arch Dermatol. 1979;115(11):1315–6.PubMedGoogle Scholar
  86. 86.
    Van Geertruyden J, Lorea P, Goldschmidt D, de Fontaine S, Schuind F, Kinnen L, et al. Glomus tumors of the hand: a retrospective study of 51 cases. J Hand Surg Br. 1996;21(2):257–60.PubMedGoogle Scholar
  87. 87.
    Richert B, Lecerf P, Caucanas M, André J. Nail tumors. Clin Dermatol. 2013;31(5):602–17.PubMedGoogle Scholar
  88. 88.
    Jablon M, Horowitz A, Bernstein DA. Magnetic resonance imaging of a glomus tumor of the fingertip. J Hand Surg Am. 1990;15(3):507–9.PubMedGoogle Scholar
  89. 89.
    Drapé JL, Idy-Peretti I, Goettmann S, Guérin-Surville H, Bittoun J. Standard and high resolution magnetic resonance imaging of glomus tumors of toes and fingertips. J Am Acad Dermatol. 1996;35(4):550–5.PubMedGoogle Scholar
  90. 90.
    Richert B, Baghaie M. Medical imaging and MRI in nail disorders: report of 119 cases and review. Dermatol Ther. 2002;15(2):159–64.Google Scholar
  91. 91.
    Lin YC, Hsiao PF, Wu YH, Sun FJ, Scher RK. Recurrent digital glomus tumor: analysis of 75 cases. Dermatol Surg. 2010;36(9):1396–400.PubMedGoogle Scholar
  92. 92.
    Lecerf P, Richert B, Theunis A, André J. A retrospective study of squamous cell carcinoma of the nail unit diagnosed in a Belgian general hospital over a 15-year period. J Am Acad Dermatol. 2013;69(2):253–61.PubMedGoogle Scholar
  93. 93.
    Riddel C, Rashid R, Thomas V. Ungual and periungual human papillomavirus-associated squamous cell carcinoma: a review. J Am Acad Dermatol. 2011;64(6):1147–53.PubMedGoogle Scholar
  94. 94.
    Attiyeh FF, Shah J, Booher RJ, Knapper WH. Subungual squamous cell carcinoma. JAMA. 1979;241(3):262–3.PubMedGoogle Scholar
  95. 95.
    Hale LR, Dawber RP. Subungual squamous cell carcinoma presenting with minimal nail changes: a factor in delayed diagnosis? Australas J Dermatol. 1998;39(2):86–8.PubMedGoogle Scholar
  96. 96.
    Zaiac MN, Weiss E. Mohs micrographic surgery of the nail unit and squamous cell carcinoma. Dermatol Surg. 2001;27(3):246–51.PubMedGoogle Scholar
  97. 97.
    Lumpkin LR, Rosen T, Tschen JA. Subungual squamous cell carcinoma. J Am Acad Dermatol. 1984;11(4 Pt 2):734–8.Google Scholar
  98. 98.
    Dika E, Piraccini BM, Balestri R, Vaccari S, Misciali C, Patrizi A, et al. Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases. Our experience and a long-term follow-up. Br J Dermatol. 2012;167(6):1310–4.PubMedGoogle Scholar
  99. 99.
    Banfield CC, Redburn JC, Dawber RPR. The incidence and prognosis of nail apparatus melanoma: a retrospective study of 105 patients in four English regions. Br J Dermatol. 1998;139(2):276–9.PubMedGoogle Scholar
  100. 100.
    Blessing K, Kernohan NM, Park KGM. Subungual malignant melanoma: clinicopathologic features of 100 cases. Histopathology. 1991;19(5):425–9.PubMedGoogle Scholar
  101. 101.
    Finley RK, Driscoll DL, Blumenson LE, Karakousis CP. Subungual melanoma: an eighteen-year review. Surgery. 1994;116(1):96–100.PubMedGoogle Scholar
  102. 102.
    Kato T, Suetake T, Sugiyama Y, Tabata N, Tagami H. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol. 1996;134(3):383–7.PubMedGoogle Scholar
  103. 103.
    Thai KE, Young R, Sinclair RD. Nail apparatus melanoma. Australas J Dermatol. 2001;42(2):71–81.PubMedGoogle Scholar
  104. 104.
    Thomas L, Zook EG, Haneke E, Drapé JL, Baran R, Kreusch JF. Tumors of the nail apparatus and adjacent tissues. In: Baran R, de Berker DAR, Holzbert M, Thomas L, editors. Baran & Dawber’s diseases of the nails and their management. 4th ed. Oxford: Blackwell; 2012. p. 637–743.Google Scholar
  105. 105.
    Cohen T, Busam KJ, Patel A, Brady MS. Subungal melanoma: management considerations. Am J Surg. 2008;195(2):244–8.PubMedGoogle Scholar
  106. 106.
    Quinn MJ, Thompson JE, Crotty K, McCarthy WH, Coates AS. Subungual melanoma of the hand. J Hand Surg Am. 1996;21(3):506–11.PubMedGoogle Scholar
  107. 107.
    Tan KB, Moncrieff M, Thompson JF, McCarthy SW, Shaw HM, Quinn MJ, et al. Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting. Am J Surg Pathol. 2007;31(12):1902–12.PubMedGoogle Scholar
  108. 108.
    Nguyen JT, Bakri K, Nguyen EC, Johnson CH, Moran SL. Surgical management of subungual melanoma: Mayo Clinic experience of 124 cases. Ann Plast Surg. 2013;71(4):346–54.PubMedGoogle Scholar
  109. 109.
    Saida T. Heterogeneity of the site of origin of malignant melanoma in ungual areas: “Subungual” malignant melanoma may be a misnomer. Br J Dermatol. 1992;126(5):529.PubMedGoogle Scholar
  110. 110.
    Banfield CC, Dawber RPR. Nail melanoma: a review of the literature with recommendations to improve patient management. Br J Dermatol. 1999;141(4):628–32.PubMedGoogle Scholar
  111. 111.
    Saida T, Ohshima Y. Clinical and histopathologic characteristics of early lesions of subungual malignant melanoma. Cancer. 1989;63(3):556–60.PubMedGoogle Scholar
  112. 112.
    Levit EK, Kagen MH, Scher RK, Grossman M, Altman E. The ABC rule for clinical detection of subungal melanoma. J Am Acad Dermatol. 2000;42(2 Pt 1):269–74.PubMedGoogle Scholar
  113. 113.
    Baran R, Kechijian P. Hutchinson’s sign: a reappraisal. J Am Acad Dermatol. 1996;34(1):87–90.PubMedGoogle Scholar
  114. 114.
    Shulka VK, Hughes LE. Differential diagnosis of subungual melanoma from a surgical point of view. Br J Surg. 1989;76(11):1156–60.Google Scholar
  115. 115.
    André J, Moulonguet I, Goettmann-Bonvallot S. In situ amelanotic melanomia of the nail unit mimicking lichen planus: report of 3 cases. Arch Dermatol. 2010;146(4):418–21.PubMedGoogle Scholar
  116. 116.
    Martin DE, English JC, Goitz RJ. Subungual malignant melanoma. J Hand Surg Am. 2011;36(4):704–7.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of DermatologyStanford University School of MedicineRedwood CityUSA

Personalised recommendations